Evaluation of compliance with legal requirements under the FDA Amendments Act 2007 for timely registration of clinical trials, data verification, delayed reporting, and trial document submission
The US Food and Drug Administration (FDA) Amendments Act of 2007 (FDAAA 2007), as further clarified by regulations effective in 2017 (the Final Rule), requires sponsors of clinical trials covered by the legal requirements to register and report clinical trials to ClinicalTrials.gov.1 In a previous r...
Main Authors: | DeVito, N, Goldacre, B |
---|---|
Format: | Journal article |
Language: | English |
Published: |
American Medical Association
2021
|
Similar Items
-
Association of the FDA Amendment Act with trial registration, publication, and outcome reporting
by: Adam T. Phillips, et al.
Published: (2017-07-01) -
Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study
by: DeVito, NJ, et al.
Published: (2020) -
Noncommercial funders' policies on trial registration, access to summary results, and individual patient data availability
by: DeVito, NJ, et al.
Published: (2018) -
E-cigarette manufacturers’ compliance with clinical trial reporting expectations: a case series of registered trials by Juul Labs, Inc.
by: DeVito, N, et al.
Published: (2021) -
You can now search FDA approval documents easily at fda.opentrials.net
by: Goldacre, B, et al.
Published: (2017)